NASDAQ · VIVS
VivoSim Labs, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for VIVS: Nov 5, 2026
VivoSim Labs, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.98.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative- RTTNews · Oct 7, 8:36 AM EDTVivoSim Labs Highlights FDA Pathway For Human-Based Safety Testing;Stock Up(RTTNews) – VivoSim Labs, Inc. (VIVS), a provider of next-generation New Approach Methodologies (NAM) 3D human cellular models for preclinical safety, highlighted the FDA's updated regulations allowing greater use of non-animal testing methods for drugs and biological products in
- RTTNews · Sep 16, 8:32 AM EDTVivoSim Labs Presents New NAMkind Data At EUROTOX 2026(RTTNews) – VivoSim Labs, Inc. (VIVS), a pharmaceutical and biotechnology services company focused on 3D human liver and intestinal tissue models, announced new data from its NAMkind platform at EUROTOX 2026 in Vienna, highlighting its potential to predict drug toxicity across sm
- RTTNews · Jul 16, 10:20 AM EDTVivoSim Prices $4.0 Million Private Placement To Support NAM Technology Development; Stock Down(RTTNews) – VivoSim Labs, Inc. (VIVS) announced it has priced a $4.0 million private placement with a single healthcare focused institutional investor, structured at-the-market under Nasdaq rules. The financing includes the purchase of 4,705,883 shares of common stock and warrant
- RTTNews · Apr 1, 8:38 AM EDTVivoSim Labs Fall 34% After Pricing Up To $4 Million Public Offering(RTTNews) – Shares if VivoSim Labs, Inc. (VIVS) are down about 34% in pre-market trading after the company announced the pricing of up to a $4 million best-efforts public offering, structured across two closings.
- RTTNews · Jan 30, 4:45 AM ESTVivoSim Expands Asia-Pacific Access To NAMKind Toxicology Services; Stock Skyrockets(RTTNews) – Shares of VivoSim Labs, Inc. (VIVS) are up in the overnight session by 145%, as the company has expanded commercial access to its NAMKind human-based toxicology services across the Asia-Pacific region through new distributor agreements in Korea and China.
- Quiver Quantitative · May 7, 8:13 AM EDTVivoSim Labs, Inc. Showcases NAMkind™ Platform's Industry-Leading Liver Toxicology Prediction at Digestive Disease Week ConferenceVivoSim Labs' NAMkind™ platform shows 87.5% predictive accuracy for liver toxicity, enhancing drug safety and reducing development costs.
- Quiver Quantitative · Apr 24, 8:15 AM EDTVivoSim Labs, Inc. Emerges from Stealth Mode to Revolutionize Drug Discovery with Non-Animal Toxicology Models Following FDA InitiativeVivoSim Labs has launched non-animal toxicology models to enhance drug development, aligning with FDA's initiative to phase out animal testing.
- Quiver Quantitative · Apr 23, 8:13 AM EDTOrganovo Holdings, Inc. Announces Name Change to VivoSim Labs, Inc. and New Ticker Symbol "VIVS"Organovo Holdings, Inc. will rebrand as VivoSim Labs, Inc. on April 24, 2025, with a new stock symbol "VIVS."
- RTTNews · Mar 27, 8:51 AM EDTOrganovo Issues Business Update – Quick Facts(RTTNews) – Organovo (ONVO) issued a business update. With the closing of the sale of its FXR Program to Lilly (LLY), Organovo has received upfront payments and anticipates future milestone payments. The company believes it is well-positioned to repeat the FXR314 success with ano
- Quiver Quantitative · Mar 25, 11:30 AM EDTOrganovo Holdings, Inc. Completes Sale of FXR Program to Eli Lilly and CompanyOrganovo sold its FXR program, including FXR314, to Eli Lilly, receiving an upfront payment and future milestone incentives.
- RTTNews · Mar 19, 12:35 PM EDTOrganovo Announces 1-for-12 Reverse Stock Split To Maintain Nasdaq Compliance(RTTNews) – Organovo Holdings, Inc. (ONVO), a clinical-stage biotechnology company Wednesday announced that it will implement a 1-for-12 reverse stock split, effective at 5:00 p.m. Eastern Time on March 20, 2025.
- Quiver Quantitative · Mar 19, 8:12 AM EDTOrganovo Holdings, Inc. Announces 1-for-12 Reverse Stock Split Effective March 20, 2025Organovo Holdings will implement a 1-for-12 reverse stock split effective March 20, 2025, to meet Nasdaq listing requirements.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for VivoSim Labs, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.